PMC:7228307 / 0-214 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1","span":{"begin":33,"end":37},"obj":"Gene"},{"id":"22","span":{"begin":164,"end":169},"obj":"Species"}],"attributes":[{"id":"A1","pred":"tao:has_database_id","subj":"1","obj":"Gene:2213"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) i"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":15,"end":28},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma9825"}],"text":"Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) i"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":15,"end":28},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) i"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":121,"end":123},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0020320"}],"text":"Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) i"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":15,"end":28},"obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"id":"T2","span":{"begin":33,"end":35},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T3","span":{"begin":66,"end":67},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T4","span":{"begin":93,"end":95},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T5","span":{"begin":164,"end":169},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T6","span":{"begin":195,"end":197},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) i"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T1","span":{"begin":38,"end":46},"obj":"http://purl.obolibrary.org/obo/BFO_0000034"}],"text":"Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) i"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1","span":{"begin":33,"end":37},"obj":"Gene"},{"id":"22","span":{"begin":164,"end":169},"obj":"Species"}],"attributes":[{"id":"A1","pred":"pubann:denotes","subj":"1","obj":"Gene:2213"},{"id":"A22","pred":"pubann:denotes","subj":"22","obj":"Tax:9606"}],"text":"Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) i"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T1","span":{"begin":164,"end":169},"obj":"Species"}],"attributes":[{"id":"A1","pred":"ncbi_taxonomy_id","subj":"T1","obj":"NCBItxid:9606"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) i"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":92},"obj":"Sentence"},{"id":"T2","span":{"begin":93,"end":120},"obj":"Sentence"},{"id":"T3","span":{"begin":121,"end":140},"obj":"Sentence"},{"id":"T4","span":{"begin":142,"end":150},"obj":"Sentence"},{"id":"T5","span":{"begin":151,"end":159},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) i"}

{"project":"LitCovid-sample-PD-UBERON","denotations":[{"id":"T1","span":{"begin":15,"end":28},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) i"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T1","span":{"begin":15,"end":28},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma9825"}],"text":"Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) i"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":92},"obj":"Sentence"},{"id":"T2","span":{"begin":93,"end":120},"obj":"Sentence"},{"id":"T3","span":{"begin":121,"end":140},"obj":"Sentence"},{"id":"T4","span":{"begin":142,"end":150},"obj":"Sentence"},{"id":"T5","span":{"begin":151,"end":159},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs\nFcγR and mAb immune therapy\nAM Chenoweth et al.\n\nAbstract\nAbstract\nThe human fragment crystallizable (Fc)γ receptor (R) i"}